Los Angeles Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.25K Sell
217
-19,180
-99% -$469K ﹤0.01% 2172
2025
Q4
$478K Buy
19,397
+459
+2% +$11.8K ﹤0.01% 912
2025
Q3
$505K Buy
+18,938
New +$489K ﹤0.01% 937
2024
Q4
Sell
-16,169
Closed -$785K 1107
2024
Q3
$785K Buy
+16,169
New +$710K ﹤0.01% 729
2024
Q2
Sell
-17,428
Closed -$765K 1169
2024
Q1
$765K Hold
17,428
﹤0.01% 766
2023
Q4
$1.08M Sell
17,428
-10,015
-36% -$526K ﹤0.01% 653
2023
Q3
$1.26M Buy
27,443
+358
+1% +$19.5K 0.01% 563
2023
Q2
$1.56M Buy
27,085
+610
+2% +$27K 0.01% 545
2023
Q1
$993K Buy
26,475
+16,475
+165% +$540K ﹤0.01% 673
2022
Q4
$280K Sell
10,000
-1,755
-15% -$51K ﹤0.01% 1055
2022
Q3
$330K Hold
11,755
﹤0.01% 1046
2022
Q2
$409K Buy
11,755
+6,120
+109% +$218K ﹤0.01% 1040
2022
Q1
$202K Buy
+5,635
New +$160K ﹤0.01% 1357
2016
Q4
Sell
-14,105
Closed -$268K 1159
2016
Q3
$268K Buy
14,105
+520
+4% +$9.44K ﹤0.01% 1085
2016
Q2
$219K Sell
13,585
-1,450
-10% -$20.5K ﹤0.01% 1134
2016
Q1
$180K Buy
+15,035
New +$177K ﹤0.01% 1069

Other funds holding AMPH